@@ -105,7 +105,7 @@ export function Engineering() {
<h4>Redesign & Build</h4>
<p>During the next round of literature reading and brain storming, we learned that the level of bile acid decreases in cirrhosis patients and it was verified in some clinical studies[2-3], so we endeavored to seek systems that could respond to bile acids. Under the generous help and suggestions of Professor Zhu Bo (find more in our integrated human practice page), we found Martínez et al in 2019 developed bile acid inducible promoters in Lactobacillus strains[4]. </p>
<p>However, the level of bile acid is negatively related to the severity of cirrhosis, so we tried to utilize the "NOT" logic gate by introducing Cl/Plam genetic circuit. Plam is a potent promoter found in the lambda bacteriophage, while Cl is an inhibitory protein that can bind to the Plam promoter, thereby repressing downstream gene expression[5].</p>
<p>Next, we re-designed the sensing module as shown in Figure 2. The normal level of bile acid can activate the expression of pchA downstream of the inducible bile acid promoter, releasing transcriptional factor pchA to activate PLEE1 and express CL, which can inhibit Plam to express metabolic module. In contrast, when bile acid decreases in cirrhosis patients who are likely to develop HE, the inhibitory effect can be eliminated and thus initiate the expression of metabolic module to work.</p>
<p>Next, we re-designed the sensing module as shown in Figure 1. The normal level of bile acid can activate the expression of pchA downstream of the inducible bile acid promoter, releasing transcriptional factor pchA to activate PLEE1 and express CL, which can inhibit Plam to express metabolic module. In contrast, when bile acid decreases in cirrhosis patients who are likely to develop HE, the inhibitory effect can be eliminated and thus initiate the expression of metabolic module to work.</p>
@@ -116,7 +116,7 @@ export function Engineering() {
<h4>Test</h4>
<p>To ensure the feasibility of our design before construction of plasmids, we did broad HP investigations, literature reviews, group discussions and expert outreach. Professor Zhu Bo suggested us to interview experts in the field of liver diseases, especially in HE. Our HP group reached Professor He Xiaolong, who has been studying the mechanism of gut microbiota and its metabolites in the development of HE. He pointed out that although our design seemed very interesting, bile acids are not specific enough as a biomarker for HE. </p>
<p>Coincidentally, his team currently found a new type of gut microbiota-derived metabolite, PEA, and verified its specificity and sensitivity in animal models and patients (Figure 3, unpublished work in submission). He generously reported this work to us and showed great interest in the concept of engineering probiotics to prevent HE from progressing. Therefore, we invited him to our team as secondary PI and moved our attention to PEA as the sensor.</p>
<p>Coincidentally, his team currently found a new type of gut microbiota-derived metabolite, PEA, and verified its specificity and sensitivity in animal models and patients (Figure 2, unpublished work in submission). He generously reported this work to us and showed great interest in the concept of engineering probiotics to prevent HE from progressing. Therefore, we invited him to our team as secondary PI and moved our attention to PEA as the sensor.</p>
@@ -129,7 +129,7 @@ export function Engineering() {
<h3>Cycle 2: Construction of the Sensing Module</h3>
<h4>Design & Build</h4>
<p>To specifically respond to PEA, we designed a TynA-FeaR-PTynA inducible system. In Escherichia coli, TynA is a monoamine oxidase that can oxidize aromatic amines such as PEA to the corresponding aldehyde, PAG. FeaR is a transcription factor, which was shown to activate PtynA in the presence of aldehydes. Therefore, we designed a plasmid that constantly express TynA and FeaR and another plasmid with the inducibel promoter PTynA and downstream gene to be activated. </p>
<p>However, TynA can oxidize various kinds of aromatic amines and lack specificity to PEA. Through literature reading, we learned that Rottinghaus et al found the mutant TynA-G494S and FeaR-A81L showed a more specific response to PEA and PAG[6]. Therefore, we constructed the plasmid Pcon-FeaR+Pcon-TynA with the two mutants and a plasmid with inducible promoter PTynA and a reporter gene GFP (Figure 4).</p>
<p>However, TynA can oxidize various kinds of aromatic amines and lack specificity to PEA. Through literature reading, we learned that Rottinghaus et al found the mutant TynA-G494S and FeaR-A81L showed a more specific response to PEA and PAG[6]. Therefore, we constructed the plasmid Pcon-FeaR+Pcon-TynA with the two mutants and a plasmid with inducible promoter PTynA and a reporter gene GFP (Figure 3).</p>
